
| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| CRE_L | 28 | 11.8% | 3.93 | 426 | 66.1% |
| PLP_L | 176 | 73.9% | -3.76 | 13 | 2.0% |
| LAL_L | 10 | 4.2% | 3.91 | 150 | 23.3% |
| GA_L | 4 | 1.7% | 3.58 | 48 | 7.5% |
| LH_L | 17 | 7.1% | -inf | 0 | 0.0% |
| PVLP_L | 2 | 0.8% | 1.58 | 6 | 0.9% |
| AVLP_L | 1 | 0.4% | 0.00 | 1 | 0.2% |
| upstream partner | # | NT | conns CB3754 | % In | CV |
|---|---|---|---|---|---|
| LC27 (L) | 15 | ACh | 33 | 15.3% | 0.5 |
| MTe50 (L) | 14 | ACh | 27 | 12.6% | 0.6 |
| CB3113 (R) | 2 | ACh | 19 | 8.8% | 0.4 |
| CB3754 (L) | 1 | Glu | 12 | 5.6% | 0.0 |
| LTe38a (L) | 4 | ACh | 11 | 5.1% | 0.5 |
| CB2267_c (L) | 4 | ACh | 11 | 5.1% | 0.4 |
| LTe53 (L) | 1 | Glu | 10 | 4.7% | 0.0 |
| WED081 (R) | 1 | GABA | 10 | 4.7% | 0.0 |
| WED081 (L) | 1 | GABA | 4 | 1.9% | 0.0 |
| OA-VUMa6 (M) | 1 | OA | 4 | 1.9% | 0.0 |
| CB1056 (R) | 1 | Glu | 3 | 1.4% | 0.0 |
| PLP155 (L) | 1 | ACh | 3 | 1.4% | 0.0 |
| CB2881 (L) | 1 | Glu | 3 | 1.4% | 0.0 |
| PLP046b (L) | 2 | Glu | 3 | 1.4% | 0.3 |
| CB1510 (R) | 2 | GABA | 3 | 1.4% | 0.3 |
| LT58 (L) | 1 | Glu | 2 | 0.9% | 0.0 |
| MTe28 (L) | 1 | ACh | 2 | 0.9% | 0.0 |
| LHCENT14 (L) | 1 | Glu | 2 | 0.9% | 0.0 |
| WED044 (L) | 1 | ACh | 2 | 0.9% | 0.0 |
| PLP130 (L) | 1 | ACh | 2 | 0.9% | 0.0 |
| CB1849 (L) | 1 | ACh | 2 | 0.9% | 0.0 |
| CB2873 (L) | 1 | Glu | 2 | 0.9% | 0.0 |
| CB3755 (L) | 1 | Glu | 2 | 0.9% | 0.0 |
| PLP039 (L) | 2 | Glu | 2 | 0.9% | 0.0 |
| MTe51 (L) | 2 | ACh | 2 | 0.9% | 0.0 |
| LT43 (L) | 1 | GABA | 1 | 0.5% | 0.0 |
| CB2509 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| CB2217 (R) | 1 | ACh | 1 | 0.5% | 0.0 |
| CB2414 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| FB4L (L) | 1 | Unk | 1 | 0.5% | 0.0 |
| PLP046c (L) | 1 | Glu | 1 | 0.5% | 0.0 |
| SMP371 (L) | 1 | Glu | 1 | 0.5% | 0.0 |
| SMP370 (L) | 1 | Glu | 1 | 0.5% | 0.0 |
| SMP237 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| PLP252 (L) | 1 | Glu | 1 | 0.5% | 0.0 |
| SLP206 (L) | 1 | GABA | 1 | 0.5% | 0.0 |
| CB3082 (R) | 1 | ACh | 1 | 0.5% | 0.0 |
| CB1587 (L) | 1 | GABA | 1 | 0.5% | 0.0 |
| CB0342 (L) | 1 | GABA | 1 | 0.5% | 0.0 |
| LTe75 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| SMP188 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| CL016 (L) | 1 | Glu | 1 | 0.5% | 0.0 |
| PLP041,PLP043 (L) | 1 | Glu | 1 | 0.5% | 0.0 |
| CB2002 (L) | 1 | GABA | 1 | 0.5% | 0.0 |
| PLP048 (L) | 1 | Glu | 1 | 0.5% | 0.0 |
| CB1558 (L) | 1 | GABA | 1 | 0.5% | 0.0 |
| PLP122 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| SLP131 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| LAL087 (L) | 1 | Glu | 1 | 0.5% | 0.0 |
| SMP151 (L) | 1 | GABA | 1 | 0.5% | 0.0 |
| CRE095b (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| MTe54 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| CB3760 (L) | 1 | Glu | 1 | 0.5% | 0.0 |
| LCe01b (L) | 1 | Glu | 1 | 0.5% | 0.0 |
| CB3759 (L) | 1 | Glu | 1 | 0.5% | 0.0 |
| cL19 (L) | 1 | Unk | 1 | 0.5% | 0.0 |
| CB2950 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| LCe03 (L) | 1 | Glu | 1 | 0.5% | 0.0 |
| PLP042c (L) | 1 | Glu | 1 | 0.5% | 0.0 |
| PLP221 (R) | 1 | ACh | 1 | 0.5% | 0.0 |
| EL (R) | 1 | GABA | 1 | 0.5% | 0.0 |
| CB3709 (L) | 1 | Glu | 1 | 0.5% | 0.0 |
| CB2523 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| cM09 (L) | 1 | Glu | 1 | 0.5% | 0.0 |
| downstream partner | # | NT | conns CB3754 | % Out | CV |
|---|---|---|---|---|---|
| SMP237 (L) | 1 | ACh | 21 | 11.5% | 0.0 |
| LAL047 (L) | 1 | GABA | 21 | 11.5% | 0.0 |
| CB0429 (L) | 1 | ACh | 13 | 7.1% | 0.0 |
| CB3754 (L) | 1 | Glu | 12 | 6.6% | 0.0 |
| CB2118 (L) | 2 | ACh | 10 | 5.5% | 0.2 |
| CB3895 (L) | 2 | ACh | 9 | 4.9% | 0.1 |
| FB2A (L) | 2 | DA | 7 | 3.8% | 0.1 |
| VES054 (L) | 1 | ACh | 6 | 3.3% | 0.0 |
| SMP188 (L) | 1 | ACh | 6 | 3.3% | 0.0 |
| FB2G (L) | 2 | Glu | 5 | 2.7% | 0.2 |
| CB2881 (L) | 4 | Glu | 5 | 2.7% | 0.3 |
| PFL1 (R) | 3 | ACh | 4 | 2.2% | 0.4 |
| LAL141 (L) | 1 | ACh | 3 | 1.6% | 0.0 |
| LHCENT14 (L) | 1 | Glu | 3 | 1.6% | 0.0 |
| LAL188 (L) | 2 | ACh | 3 | 1.6% | 0.3 |
| SMP019 (L) | 2 | ACh | 3 | 1.6% | 0.3 |
| LAL009 (L) | 1 | ACh | 2 | 1.1% | 0.0 |
| LAL156b (L) | 1 | ACh | 2 | 1.1% | 0.0 |
| PLP042a (L) | 1 | Glu | 2 | 1.1% | 0.0 |
| CB2002 (L) | 1 | GABA | 2 | 1.1% | 0.0 |
| LAL163,LAL164 (L) | 1 | ACh | 2 | 1.1% | 0.0 |
| CB2276 (L) | 1 | GABA | 2 | 1.1% | 0.0 |
| WED082 (L) | 1 | GABA | 2 | 1.1% | 0.0 |
| SMP477 (L) | 1 | ACh | 2 | 1.1% | 0.0 |
| CB2430 (L) | 2 | GABA | 2 | 1.1% | 0.0 |
| CB3753 (L) | 2 | Glu | 2 | 1.1% | 0.0 |
| CB2217 (L) | 2 | ACh | 2 | 1.1% | 0.0 |
| SMP456 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| CRE018 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| FB2B_b (L) | 1 | Glu | 1 | 0.5% | 0.0 |
| CL234 (L) | 1 | Glu | 1 | 0.5% | 0.0 |
| SLP457 (L) | 1 | DA | 1 | 0.5% | 0.0 |
| cL06 (R) | 1 | GABA | 1 | 0.5% | 0.0 |
| SMP008 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| CB2509 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| FB2B (L) | 1 | Glu | 1 | 0.5% | 0.0 |
| FB1G (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| SMP006 (R) | 1 | ACh | 1 | 0.5% | 0.0 |
| PLP041,PLP043 (L) | 1 | Glu | 1 | 0.5% | 0.0 |
| SMP151 (L) | 1 | GABA | 1 | 0.5% | 0.0 |
| CB2873 (L) | 1 | Glu | 1 | 0.5% | 0.0 |
| CRE015 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| CB0942 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| SMP457 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| CB1841 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| LHPV5l1 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| FB2D (L) | 1 | Glu | 1 | 0.5% | 0.0 |
| PLP048 (L) | 1 | Glu | 1 | 0.5% | 0.0 |
| ALIN3 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| CB3895 (R) | 1 | ACh | 1 | 0.5% | 0.0 |
| LAL142 (L) | 1 | GABA | 1 | 0.5% | 0.0 |
| CB1202 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| PLP046b (L) | 1 | Glu | 1 | 0.5% | 0.0 |
| SMP371 (L) | 1 | Glu | 1 | 0.5% | 0.0 |
| CB2565 (R) | 1 | ACh | 1 | 0.5% | 0.0 |
| CB2245 (L) | 1 | GABA | 1 | 0.5% | 0.0 |